Skip to content

H.R. 2213 · 119th Congress (2025–2027)

Medical Supply Chain Resiliency Act

This bill authorizes actions to facilitate trade in medical goods (i.e., medical devices, pharmaceutical goods, or inputs for such devices or goods).

Specifically, the bill authorizes the President to (1) negotiate, enter into, and enforce a trusted trade partner agreement with a country or countries with respect to medical goods; and (2) proclaim a modification of any existing duty, a continuance of existing duty-free or excise treatment, or additional duties to carry out the trade agreement. These actions may only be taken if the President determines, based on specified considerations, that the reciprocal elimination of existing duties or other import restrictions with respect to medical goods would contribute to U.S. national security and public health.

A trusted trade partner agreement may include certain provisions, such as those to (1) reduce or eliminate duties, quotas, or other trade barriers; (2) diversify and expand supplier networks to secure a reliable supply of medical goods; and (3) harmonize regulatory procedures.

Not later than 60 days before initiating negotiations with a trusted trade partner, the President must submit written notice to Congress. The bill requires congressional consultation and review of these trade agreements. A trade agreement shall not take effect if, during the required review period, Congress enacts a joint resolution of disapproval.

The Office of the U.S. Trade Representative must monitor compliance by a trusted trade partner with the trade agreement's commitments and obligations. Further, the President may take certain actions in response to a failure to comply.

Show official title

To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 2213’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Nicole Malliotakis (R-NY-11)
Cosponsors
21 cosponsors

1 original · 20 later

7 R · 14 D

  1. Rep. Bradley Scott Schneider (D-IL-10)· Original · Mar 18, 2025
  2. Rep. Jake Auchincloss (D-MA-4)· Later · Apr 28, 2025
  3. Rep. Donald G. Davis (D-NC-1)· Later · May 5, 2025
  4. Rep. Mike Kelly (R-PA-16)· Later · May 29, 2025
  5. Rep. Carol D. Miller (R-WV-1)· Later · Jun 25, 2025
  6. Rep. Al Green (D-TX-9)· Later · Jun 26, 2025
  7. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Jul 15, 2025
  8. Rep. Deborah K. Ross (D-NC-2)· Later · Jul 16, 2025
  9. Rep. Gregory F. Murphy (R-NC-3)· Later · Jul 29, 2025
  10. Rep. Thomas R. Suozzi (D-NY-3)· Later · Jul 29, 2025
  11. Rep. Josh Gottheimer (D-NJ-5)· Later · Aug 5, 2025
  12. Rep. Eugene Simon Vindman (D-VA-7)· Later · Sep 9, 2025
  13. Rep. Max L. Miller (R-OH-7)· Later · Sep 16, 2025
  14. Rep. Steven Horsford (D-NV-4)· Later · Dec 1, 2025
  15. Rep. Laura Gillen (D-NY-4)· Later · Dec 18, 2025
  16. Rep. Claudia Tenney (R-NY-24)· Later · Jan 6, 2026
  17. Rep. Julie Johnson (D-TX-32)· Later · Jan 30, 2026
  18. Del. Stacey E. Plaskett (D-VI)· Later · Jan 30, 2026
  19. Rep. Darin LaHood (R-IL-16)· Later · Feb 4, 2026
  20. Rep. Sharice Davids (D-KS-3)· Later · Aug 27, 2026
  21. Rep. J. Luis Correa (D-CA-46)· Later · Sep 15, 2026
Policy area
Foreign Trade and International Finance

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseRulesReferred Mar 18, 2025
  2. HouseWays and MeansReferred Mar 18, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Medical Supply Chain Resiliency Act

    Display title, Short title · Introduced in House

  2. To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes.

    Official title · Introduced in House